RT @MichaelBaum11: @organiclemon @trishgreenhalgh @PatientAdvocac4 @Liz_ORiordan Here is a reference to a study based at University College…
@organiclemon @trishgreenhalgh @PatientAdvocac4 @Liz_ORiordan Here is a reference to a study based at University College London, in which I acted as chairman of the data monitoring committee. https://t.co/20hADKt75S
@cecilejanssens @orenzusman @amitvkhera @skathire Your math seems fine. AUC doesn't require continuity, if you compute from how often a randomly selected case and control are correctly ordered. Here are two BRCA cost effectiveness studies: https://t.co/M
Our final question(s)! 1. Which correlation coefficient should you use when calculating for variables which are... https://t.co/Bk9BYnynnl
Cost-effect of Pop Screening 4 #BRCA Mutations in Ashkenazi Jewish Women Vs. W/ Family History Based Test @JNCI_Now http://t.co/OA6nnJ3glt
.@JNCI_Now reports on cost-effectiveness of screening for #BRCA mutations in #Ashkenazi #Jewish women. Read it here: http://t.co/4SVX12SGEV
.@JNCI_Now reports on cost-effectiveness of screening for #BRCA mutations in #Ashkenazi #Jewish women. Read it here: http://t.co/4SVX12SGEV
New study looking at cost of screening for BRCA mutations in Ashkenazi Jewish women: http://t.co/Nn9qHK8nBb
Cost-effective of Pop Screen 4 #BRCA Mutations in #AshkenaziJewish Women Compared W/ Family Hx Based Test. @JNCI_Now http://t.co/VnYQTDsLSz
Population screening for BRCA mutations in Ashkenazi Jewish population is cost-effective http://t.co/VJHT5wAkVo
Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family… http://t.co/LsrH7ZewZ9
◈ Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Fa... http://t.co/sUgUoLeL76 ◈